Company Filing History:
2 out of 26 
1 out of 1 Years Active: 1999
Title: Innovations by Gian Visentin in Thrombocytopenia Detection
Introduction
Gian Visentin is an accomplished inventor based in Shorewood, Wisconsin, known for his significant contributions to the field of medical diagnostics. He holds two patents that focus on methods for detecting heparin-induced thrombocytopenia (HITP), a condition that can lead to serious complications in patients receiving heparin treatment. His innovative approaches aim to improve the accuracy and efficiency of diagnosing this condition.
Latest Patents
Visentin's latest patents include a method and kit for detecting heparin-induced antibodies. The first patent describes a method that involves attaching a glycosaminoglycan to a solid support in a unidirectional manner. This method allows for the binding of platelet factor 4 to the glycosaminoglycan, forming a complex that can be analyzed for HITP-related antibodies in human blood plasma or serum. The second patent outlines a similar method but utilizes a linear, non-glycosaminoglycan polymer with distributed negative charges. This innovative approach also leads to the formation of a complex that can be used to detect HITP-related antibodies in patients.
Career Highlights
Throughout his career, Gian Visentin has worked with notable organizations such as the BloodCenter Research Foundation and the Genetics Testing Institute. His work in these institutions has contributed to advancements in medical research and diagnostics, particularly in the area of thrombocytopenia.
Collaborations
Visentin has collaborated with esteemed colleagues, including Richard H. Aster and Manouchehr Moghaddam. These partnerships have fostered a collaborative environment that enhances the development of innovative diagnostic methods.
Conclusion
Gian Visentin's contributions to the field of medical diagnostics, particularly in the detection of heparin-induced thrombocytopenia, showcase his dedication to improving patient care through innovation. His patents reflect a commitment to advancing medical technology and enhancing diagnostic accuracy.